722
Views
2
CrossRef citations to date
0
Altmetric
Reviews

Lactoferrin for Mental Health: Neuro-Redox Regulation and Neuroprotective Effects across the Blood-Brain Barrier with Special Reference to Neuro-COVID-19

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon

References

  • Abdelhamid M, Jung CG, Zhou C, Abdullah M, Nakano M, Wakabayashi H, Abe F, Michikawa M. 2020. Dietary lactoferrin supplementation prevents memory impairment and reduces amyloid-β generation in J20 Mice. J Alzheimers Dis. 74(1):245–259. doi:10.3233/JAD-191181. PMID: 31985470.
  • Acharya A, Kevadiya BD, Gendelman HE, Byrareddy SN. 2020. SARS-CoV-2 infection leads to neurological dysfunction. J Neuroimmune Pharmacol. 15(2):167–173. doi:10.1007/s11481-020-09924-9. Epub 2020 May 23. PMID: 32447746; PMCID: PMC7244399.
  • Aguilera G, Colín-González AL, Rangel-López E, Chavarría A, Santamaría A. 2018. Redox signaling, neuroinflammation, and neurodegeneration. Antioxid Redox Signal. 28(18):1626–1651. doi:10.1089/ars.2017.7099. Epub 2017 Jun 6. PMID: 28467722.
  • Agwa MM, Abdelmonsif DA, Khattab SN, Sabra S. 2020. Self- assembled lactoferrin-conjugated linoleic acid micelles as an orally active targeted nanoplatform for Alzheimer's disease. Int J Biol Macromol. 162:246–261. doi:10.1016/j.ijbiomac.2020.06.058. Epub 2020 Jun 9. PMID: 32531361.
  • Akilo OD, Kumar P, Choonara YE, Pradeep P, Du Toit LC, Pillay V. 2018. Hypothesis: apo-lactoferrin-Galantamine Proteo-alkaloid conjugate for Alzheimer's disease intervention. J Cell Mol Med. 22(3):1957–1963. doi:10.1111/jcmm.13484. Epub 2018 Jan 29. PMID: 29377514; PMCID: PMC5824407.
  • Aleshina GM, Yankelevich IA, Zhakharova ET, Kokryakov VN. 2016. Stress-protective effect of human lactoferrin. Ross Fiziol Zh Im I M Sechenova. 102(7):846–51. Russian. PMID: 30193052.
  • An L, Sato H, Konishi Y, Walker DG, Beach TG, Rogers J, Tooyama I. 2009. Expression and localization of lactotransferrin messenger RNA in the cortex of Alzheimer's disease. Neurosci Lett. 452(3):277–280. doi:10.1016/j.neulet.2009.01.071. Epub 2009 Feb 4. PMID: 19348738; PMCID: PMC2667624.
  • Andersen JH, Jenssen H, Sandvik K, Gutteberg TJ. 2004. Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface. J Med Virol. 74(2):262–271. doi:10.1002/jmv.20171. PMID: 15332275.
  • Antonini A, Leta V, Teo J, Chaudhuri KR. 2020. Outcome of Parkinson's Disease patients affected by COVID-19. Mov Disord. 35(6):905–908. doi:10.1002/mds.28104. Epub 2020 May 28. PMID: 32347572; PMCID: PMC7267273.
  • Arcella A, Oliva MA, Staffieri S, Aalberti S, Grillea G, Madonna M, Bartolo M, Pavone L, Giangaspero F, Cantore G, et al. 2015. In vitro and in vivo effect of human lactoferrin on glioblastoma growth. J Neurosurg. 123(4):1026–1035. doi:10.3171/2014.12.JNS14512. Epub 2015 Jul 17. PMID: 26186026.
  • Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, Wang M. 2020. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 323(14):1406–1407. doi:10.1001/jama.2020.2565. PMID: 32083643; PMCID: PMC7042844.
  • Battaglia AM, Chirillo R, Aversa I, Sacco A, Costanzo F, Biamonte F. 2020. Ferroptosis and cancer: Mitochondria meet the "iron maiden. Cell Death. Cells. 9(6):1505. PMID: 32575749; PMCID: PMC7349567. doi:10.3390/cells9061505.
  • Berlutti F, Pantanella F, Natalizi T, Frioni A, Paesano R, Polimeni A, Valenti P. 2011. Antiviral properties of lactoferrin–a natural immunity molecule. Molecules. 16(8):6992–7018. doi:10.3390/molecules16086992. PMID: 21847071; PMCID: PMC6264778.
  • Bermejo-Pareja F, Del Ser T, Valentí M, de la Fuente M, Bartolome F, Carro E. 2020. Salivary lactoferrin as biomarker for Alzheimer's disease: Brain-immunity interactions. Alzheimers Dement. 16(8):1196–1204. doi:10.1002/alz.12107. Epub 2020 Jun 16. PMID: 32543760.
  • Bolaños JP. 2016. Bioenergetics and redox adaptations of astrocytes to neuronal activity. J Neurochem. 139(Suppl 2):115–125. doi:10.1111/jnc.13486. Epub 2016 Mar 10. PMID: 26968531; PMCID: PMC5018236.
  • Bothwell MY, Gillette MU. 2018. Circadian redox rhythms in the regulation of neuronal excitability. Free Radic Biol Med. 119:45–55. doi:10.1016/j.freeradbiomed.2018.01.025. Epub 2018 Feb 2. PMID: 29398284; PMCID: PMC5910288.
  • Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. 2003. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 24(2):197–211. doi:10.1016/s0197-4580(02)00065-9. PMID: 12498954.
  • Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, Rubin GJ. 2020. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 395(10227):912–920. Epub 2020 Feb 26. PMID: 32112714; PMCID: PMC7158942. doi:10.1016/S0140-6736(20)30460-8.
  • Bullen JJ, Rogers HJ, Spalding PB, Ward CG. 2006. Natural resistance, iron and infection: a challenge for clinical medicine. J Med Microbiol. 55(Pt 3):251–258. doi:10.1099/jmm.0.46386-0. PMID: 16476787.
  • Campione E, Cosio T, Rosa L, Lanna C, Di Girolamo S, Gaziano R, Valenti P, Bianchi L. 2020. Lactoferrin as protective natural barrier of respiratory and intestinal mucosa against coronavirus infection and inflammation. Int. IJMS. 21(14):4903. PMID: 32664543; PMCID: PMC7402319. doi:10.3390/ijms21144903.
  • Campos-Bedolla P, Walter FR, Veszelka S, Deli MA. 2014. Role of the blood-brain barrier in the nutrition of the central nervous system. Arch Med Res. 45(8):610–638. doi:10.1016/j.arcmed.2014.11.018. Epub 2014 Dec 3. PMID: 25481827.
  • Cantuti-Castelvetri L, Ojha R, Pedro LD, Djannatian M, Franz J, Kuivanen S, van der Meer F, Kallio K, Kaya T, Anastasina M, Smura T, Levanov L, Szirovicza L, Tobi A, Kallio-Kokko H, Österlund P, Joensuu M, Meunier FA, Butcher SJ, Winkler MS, Mollenhauer B, Helenius A, Gokce O, Teesalu T, Hepojoki J, Vapalahti O, Stadelmann C, Balistreri G, Simons M. 2020. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. 370(6518):856–860. doi:10.1126/science.abd2985. Epub 2020 Oct 20. PMID: 33082293.
  • Carod-Artal FJ. 2020. Neurological complications of coronavirus and COVID-19. Rev Neurol. 70(9):311–322. English, Spanish. doi:10.33588/rn.7009.2020179. PMID: 32329044.
  • Carro E, Bartolomé F, Bermejo-Pareja F, Villarejo-Galende A, Molina JA, Ortiz P, Calero M, Rabano A, Cantero JL, Orive G. 2017. Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin. Alzheimers Dement (Amst). 8:131–138. doi:10.1016/j.dadm.2017.04.002. PMID: 28649597; PMCID: PMC5470603.
  • Chang R, Ng TB, Sun WZ. 2020. Lactoferrin as potential preventative and adjunct treatment for COVID-19. Int J Antimicrob Agents. 56(3):106118. doi:10.1016/j.ijantimicag.2020.106118. Epub 2020 Jul 30. PMID: 32738305; PMCID: PMC7390755.
  • Chen H, Qin Y, Zhang Q, Jiang W, Tang L, Liu J, He Q. 2011. Lactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomas. Eur J Pharm Sci. 44(1–2):164–173. doi:10.1016/j.ejps.2011.07.007. Epub 2011 Jul 18. PMID: 21782939.
  • Chen Y, Zheng Z, Zhu X, Shi Y, Tian D, Zhao F, Liu N, Hüppi PS, Troy FA, Wang B. 2015. Lactoferrin promotes early neurodevelopment and cognition in postnatal piglets by upregulating the BDNF signaling pathway and polysialylation. Mol Neurobiol. 52(1):256–269. doi:10.1007/s12035-014-8856-9.
  • Covino M, De Matteis G, Santoro M, Sabia L, Simeoni B, Candelli M, Ojetti V, Franceschi F. 2020. Clinical characteristics and prognostic factors in COVID-19 patients aged ≥80 years. Geriatr Gerontol Int. 20(7):704–708. doi:10.1111/ggi.13960. Epub 2020 Jun 9. PMID: 32516861; PMCID: PMC7300699.
  • Cserép C, Pósfai B, Lénárt N, Fekete R, László ZI, Lele Z, Orsolits B, Molnár G, Heindl S, Schwarcz AD, Ujvári K, Környei Z, Tóth K, Szabadits E, Sperlágh B, Baranyi M, Csiba L, Hortobágyi T, Maglóczky Z, Martinecz B, Szabó G, Erdélyi F, Szipőcs R, Tamkun MM, Gesierich B, Duering M, Katona I, Liesz A, Tamás G, Dénes Á. 2020. Microglia monitor and protect neuronal function through specialized somatic purinergic junctions. Science. 367(6477):528–537. doi:10.1126/science.aax6752. Epub 2019 Dec 12. PMID: 31831638.
  • Cuddapah VA, Zhang SL, Sehgal A. 2019. Regulation of the blood-brain barrier by circadian rhythms and sleep. Trends Neurosci. 42(7):500–510. doi:10.1016/j.tins.2019.05.001. PMID: 31253251; PMCID: PMC6602072.
  • Cutone A, Colella B, Pagliaro A, Rosa L, Lepanto MS, Bonaccorsi di Patti MC, Valenti P, Di Bartolomeo S, Musci G. 2020. Native and iron-saturated bovine lactoferrin differently hinder migration in a model of human glioblastoma by reverting epithelial-to-mesenchymal transition-like process and inhibiting interleukin-6/STAT3 axis. Cell Signal. 65:109461. doi:10.1016/j.cellsig.2019.109461. Epub 2019 Nov 1. PMID: 31678680.
  • Cutone A, Rosa L, Ianiro G, Lepanto MS, Bonaccorsi di Patti MC, Valenti P, Musci G. 2020. Lactoferrin's anti-cancer properties: Safety, selectivity, and wide range of action. Biomolecules. 10(3):456. PMID: 32183434; PMCID: PMC7175311. doi:10.3390/biom10030456.
  • Davies KJ. 1995. Oxidative stress: the paradox of aerobic life. Biochem Soc Symp. 61:1–31. doi:10.1042/bss0610001. PMID: 8660387.
  • de Haan CA, Li Z, Te Lintelo E, Bosch BJ, Haijema BJ, Rottier PJ. 2005. Murine coronavirus with an extended host range uses heparan sulfate as an entry receptor. J Virol. 79(22):14451–14456. doi:10.1128/JVI.79.22.14451-14456.2005. PMID: 16254381; PMCID: PMC1280238.
  • Dean T, Jr, Allen RP, O'Donnell CP, Earley CJ. 2006. The effects of dietary iron deprivation on murine circadian sleep architecture. Sleep Med. 7(8):634–640. doi:10.1016/j.sleep.2006.07.002. Epub 2006 Nov 13. PMID: 17098470.
  • Descamps L, Dehouck MP, Torpier G, Cecchelli R. 1996. Receptor-mediated transcytosis of transferrin through blood-brain barrier endothelial cells. Am J Physiol. 270(4 Pt 2):H1149–58. doi:10.1152/ajpheart.1996.270.4.H1149. PMID: 8967351.
  • Dringen R. 2005. Oxidative and antioxidative potential of brain microglial cells. Antioxid Redox Signal. 7(9–10):1223–1233. doi:10.1089/ars.2005.7.1223.
  • Elzoghby AO, Abdelmoneem MA, Hassanin IA, Abd Elwakil MM, Elnaggar MA, Mokhtar S, Fang JY, Elkhodairy KA. 2020. Lactoferrin, a multi-functional glycoprotein: Active therapeutic, drug nanocarrier & targeting ligand. Biomaterials. 263:120355. doi:10.1016/j.biomaterials.2020.120355. Epub 2020 Sep 9. PMID: 32932142; PMCID: PMC7480805.
  • Falsaperla R, Lombardo F, Filosco F, Romano C, Saporito MAN, Puglisi F, Piro E, Ruggieri M, Pavone P. 2020. Oxidative stress in preterm infants: overview of current evidence and future prospects. Pharmaceuticals (Basel). 13(7):145. PMID: 32645921; PMCID: PMC7408528. doi:10.3390/ph13070145.
  • Faucheux BA, Nillesse N, Damier P, Spik G, Mouatt-Prigent A, Pierce A, Leveugle B, Kubis N, Hauw JJ, Agid Y. 1995. Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease. Proc Natl Acad Sci U S A. 92(21):9603–9607. doi:10.1073/pnas.92.21.9603.
  • Ferini-Strambi L, Salsone M. 2021. COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable? J Neurol. 268(2):409–411. Epub ahead of print. PMID: 32696341; PMCID: PMC7372546. doi:10.1007/s00415-020-10070-8.
  • Fernández-Musoles R, Castelló-Ruiz M, Arce C, Manzanares P, Ivorra MD, Salom JB. 2014. Antihypertensive mechanism of lactoferrin-derived peptides: angiotensin receptor blocking effect. J Agric Food Chem. 62(1):173–181. Epub 2013 Dec 26. PMID: 24354413. doi:10.1021/jf404616f.
  • Fillebeen C, Descamps L, Dehouck MP, Fenart L, Benaïssa M, Spik G, Cecchelli R, Pierce A. 1999. Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier. J Biol Chem. 274(11):7011–7017. doi:10.1074/jbc.274.11.7011. PMID: 10066755.
  • Fillebeen C, Dexter D, Mitchell V, Benaıssa M, Beauvillain JC, Spik G, Pierce A. 1998. XX in advances in lactoferrin research. Spik G, Legrand D, Mazurier J, Perraudin JP, Pierce A, editors. New York: Plenum Press. p. 296–300.
  • Fillebeen C, Mitchell V, Dexter D, Benaissa M, Beauvillain J, Spik G, Pierce A. 1999. Lactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment. Brain Res Mol Brain Res. 72(2):183–194. doi:10.1016/S0169-328X(99)00221-1.
  • Fillebeen C, Ruchoux M-M, Mitchell V, Vincent S, Benaı¨Ssa M, Pierce A. 2001. Lactoferrin is synthesized by activated microglia in the human substantia nigra and its synthesis by the human microglial CHME cell line is upregulated by tumor necrosis factor alpha or 1-methyl-4-phenylpyridinium treatment. Brain Res Mol Brain Res. 96(1–2):103–113. doi:10.1016/S0169-328X(01)00216-9.
  • Franco R, Vargas MR. 2018. Redox biology in neurological function, dysfunction, and aging. Antioxid Redox Signal. 28(18):1583–1586. doi:10.1089/ars.2018.7509. Epub 2018 Apr 23. PMID: 29634346; PMCID: PMC5962327.
  • Frioni A, Conte MP, Cutone A, Longhi C, Musci G, di Patti MC, Natalizi T, Marazzato M, Lepanto MS, Puddu P, et al. 2014. Lactoferrin differently modulates the inflammatory response in epithelial models mimicking human inflammatory and infectious diseases. Biometals. 27(5):843–856. Epub 2014 Apr 26. PMID: 24770943. doi:10.1007/s10534-014-9740-9.
  • Gane SB, Kelly C, Hopkins C. 2020. Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome? Rhinology. 58(3):299–301. doi:10.4193/Rhin20.114. PMID: 32240279.
  • Gomez-Pinedo U, Matias-Guiu J, Sanclemente-Alaman I, Moreno-Jimenez L, Montero-Escribano P, Matias-Guiu JA. 2020. Is the brain a reservoir organ for SARS-CoV2? J Med Virol. 92(11):2354–2355. doi:10.1002/jmv.26046. Epub 2020 Jun 2. PMID: 32437002; PMCID: PMC7280610.
  • González-Sánchez M, Bartolome F, Antequera D, Puertas-Martín V, González P, Gómez-Grande A, Llamas-Velasco S, Herrero-San Martín A, Pérez-Martínez D, Villarejo-Galende A, et al. 2020. Decreased salivary lactoferrin levels are specific to Alzheimer's disease. EBioMedicine. 57:102834. doi:10.1016/j.ebiom.2020.102834. Epub 2020 Jun 22. PMID: 32586758; PMCID: PMC7378957.
  • Gothwal A, Nakhate KT, Alexander A, Ajazuddin, Gupta U. 2018. Boosted memory and improved brain bioavailability of Rivastigmine: Targeting effort to the brain using covalently tethered lower generation PAMAM Dendrimers with Lactoferrin. Mol Pharm. 15(10):4538–4549. Epub 2018 Aug 29. PMID: 30156844. doi:10.1021/acs.molpharmaceut.8b00537.
  • Guo C, Yang ZH, Zhang S, Chai R, Xue H, Zhang YH, Li JY, Wang ZY. 2017. Intranasal lactoferrin enhances α-secretase-dependent amyloid precursor protein processing via the ERK1/2-CREB and HIF-1α pathways in an Alzheimer's Disease mouse model. Neuropsychopharmacology. 42(13):2504–2515. doi:10.1038/npp.2017.8. Epub 2017 Jan 12. PMID: 28079060; PMCID: PMC5686501.
  • Gupta A, Madhavan MV, Sehgal K. 2020. Extrapulmonary manifestations of COVID-19. Nat Med. 26:1017–1032. doi:10.1038/s41591-020-0968-3.
  • Hällgren R, Terént A, Venge P. 1982. Lactoferrin, lysozyme, and beta 2-microglobulin levels in cerebrospinal fluid: differential indices of CNS inflammation. Inflammation. 6(3):291–304. doi:10.1007/BF00916410. PMID: 6182098.
  • Han C, Liu Y, Dai R, Ismail N, Su W, Li B. 2020. Ferroptosis and its potential role in human diseases. Front Pharmacol. 11:239. doi:10.3389/fphar.2020.00239. PMID: 32256352; PMCID: PMC7090218.
  • Hayashida K-i, Takeuchi T, Ozaki T, Shimizu H, Ando K, Miyamoto A, Harada E. 2004. Bovine lactoferrin has a nitric oxide-dependent hypotensive effect in rats. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 286(2):R359–R365. doi:10.1152/ajpregu.00214.2003.
  • Hayashida K, Takeuchi T, Shimizu H, Ando K, Harada E. 2003. Lactoferrin enhances opioid-mediated analgesia via nitric oxide in the rat spinal cord. Am J Physiol Regul Integr Comp Physiol. 285(2):R306–R312. doi:10.1152/ajpregu.00760.2002.
  • Heneka MT, Golenbock D, Latz E, Morgan D, Brown R. 2020. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ther. 12(1):69. doi:10.1186/s13195-020-00640-3. PMID: 32498691; PMCID: PMC7271826.
  • Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Müller MA, et al. 2020. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 181(2):271–280.e8. doi:10.1016/j.cell.2020.02.052. Epub 2020 Mar 5. PMID: 32142651; PMCID: PMC7102627.
  • Huang FY, Chen WJ, Lee WY, Lo ST, Lee TW, Lo JM. 2013. In vitro and in vivo evaluation of lactoferrin-conjugated liposomes as a novel carrier to improve the brain delivery. Int J Mol Sci. 14(2):2862–2874. doi:10.3390/ijms14022862. PMID: 23434652; PMCID: PMC3588019.
  • Huang R, Han L, Li J, Ren F, Ke W, Jiang C, Pei Y. 2009. Neuroprotection in a 6-hydroxydopamine-lesioned Parkinson model using lactoferrin-modified nanoparticles. J Gene Med. 11(9):754–763. doi:10.1002/jgm.1361.
  • Huang R, Ke W, Liu Y, Wu D, Feng L, Jiang C, Pei Y. 2010. Gene therapy using lactoferrin-modified nanoparticles in a rotenone-induced chronic Parkinson model. J Neurol Sci. 290(1–2):123–130. doi:10.1016/j.jns.2009.09.032.
  • Huang R, Ke W, Liu Y, Jiang C, Pei Y. 2008. The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain. Biomaterials. 29(2):238–246. doi:10.1016/j.biomaterials.2007.09.024. PMID: 17935779.
  • Huang RQ, Ke WL, Qu YH, Zhu JH, Pei YY, Jiang C. 2007. Characterization of lactoferrin receptor in brain endothelial capillary cells and mouse brain. J Biomed Sci. 14(1):121–128. doi:10.1007/s11373-006-9121-7.
  • Huang X, Moir RD, Tanzi RE, Bush AI, Rogers JT. 2004. Redox-active metals, oxidative stress, and Alzheimer's disease pathology. Ann N Y Acad Sci. 1012:153–163. doi:10.1196/annals.1306.012. PMID: 15105262.
  • Izumo N, Ishibashi Y, Ohba M, Morikawa T, Manabe T. 2012. Decreased voluntary activity and amygdala levels of serotonin and dopamine in ovariectomized rats. Behav Brain Res. 227(1):1–6. doi:10.1016/j.bbr.2011.10.031.
  • Jakhmola S, Indari O, Chatterjee S, Jha HC. 2020. SARS-CoV-2, an Underestimated pathogen of the nervous system. SN Compr Clin Med. 28:1–10. doi:10.1007/s42399-020-00522-7.Epub ahead of print. PMID: 33015550; PMCID: PMC7520376.
  • Jaunmuktane Z, Mahadeva U, Green A, Sekhawat V, Barrett NA, Childs L, Shankar-Hari M, Thom M, Jäger HR, Brandner S. 2020. Microvascular injury and hypoxic damage: emerging neuropathological signatures in COVID-19. Acta Neuropathol. 140(3):397–400. doi:10.1007/s00401-020-02190-2. Epub 2020 Jul 8. PMID: 32638079; PMCID: PMC7340758.
  • Ji B, Maeda J, Higuchi M, Inoue K, Akita H, Harashima H, Suhara T. 2006. Pharmacokinetics and brain uptake of lactoferrin in rats. Life Sci. 78(8):851–855. doi:10.1016/j.lfs.2005.05.085. Epub 2005 Sep 13. PMID: 16165165.
  • Jiang H, Wang J, Rogers J, Xie J. 2017. Brain iron metabolism dysfunction in Parkinson's Disease. Mol Neurobiol. 54(4):3078–3101. doi:10.1007/s12035-016-9879-1. Epub 2016 Apr 2. PMID: 27039308.
  • Kabanov AV, Batrakova EV. 2004. New technologies for drug delivery across the blood brain barrier. Curr Pharm Des. 10(12):1355–1363. doi:10.2174/1381612043384826. PMID: 15134486; PMCID: PMC2711206.
  • Kamemori N, Takeuchi T, Hayashida K, Harada E. 2004. Suppressive effects of milk-derived lactoferrin on psychological stress in adult rats. Brain Res. 1029(1):34–40. doi:10.1016/j.brainres.2004.09.015.
  • Kanwar RK, Kanwar JR. 2013. Immunomodulatory lactoferrin in the regulation of apoptosis modulatory proteins in cancer. Protein Pept Lett. 20(4):450–458. doi:10.2174/092986613805290417. PMID: 23016584.
  • Kawamata T, Tooyama I, Yamada T, Walker DG, McGeer PL. 1993. Lactotransferrin immunocytochemistry in Alzheimer and normal human brain. Am J Pathol. 142(5):1574–1585. PMID: 8494052; PMCID: PMC1886898.
  • Keep R, Ennis S, Betz A. 1998. Blood-brain barrier in ion transport. In: Pardrige W, editor. Introduction to the blood-brain barrier: methodology, biology and pathology. Cambridge: Cambridge University Press. p. 207–213. doi:10.1017/CB09780511570216.022.
  • Kessler RC, Angermeyer M, Anthony JC, on behalf of for the W.H.O. World Mental Health Survery Consortium, et al. 2007. Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry. 6(3):168–176. PMID: 18188442
  • Khan AI, Liu J, Dutta P. 2020. Bayesian inference for parameter estimation in lactoferrin-mediated iron transport across blood-brain barrier. Biochim Biophys Acta Gen Subj. 1864(3):129459. doi:10.1016/j.bbagen.2019.129459. Epub 2019 Nov 1. PMID: 31682896; PMCID: PMC6980663.
  • King GL, Johnson SM. 1985. Receptor-mediated transport of insulin across endothelial cells. Science. 227(4694):1583–1586. doi:10.1126/science.3883490. PMID: 3883490.
  • Klebanoff SJ, Waltersdorph AM. 1990. Prooxidant activity of transferrin and lactoferrin. J Exp Med. 172(5):1293–1303. doi:10.1084/jem.172.5.1293. PMID: 2230644; PMCID: PMC2188654.
  • Kopaeva Y, Cherepov AB, Zarayskaya IY, Nesterenko MV. 2019. Transport of human lactoferrin into mouse brain: Administration routes and distribution. Bull Exp Biol Med. 167(4):561–567. doi:10.1007/s10517-019-04572-3. PMID: 31502127
  • Kubota T, Kuroda N. 2021. Exacerbation of neurological symptoms and COVID-19 severity in patients with preexisting neurological disorders and COVID-19: A systematic review. Clin Neurol Neurosurg. 200:106349. Epub ahead of print. PMID: 33172719; PMCID: PMC7604080. doi:10.1016/j.clineuro.2020.106349.
  • Kumari S, Ahsan SM, Kumar JM, Kondapi AK, Rao NM. 2017. Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433). Sci Rep. 7(1):6602. doi:10.1038/s41598-017-06888-4. PMID: 28747713; PMCID: PMC5529576.
  • Kumari S, Bhattacharya D, Rangaraj N, Chakarvarty S, Kondapi AK, Rao NM. 2018. Aurora kinase B siRNA-loaded lactoferrin nanoparticles potentiate the efficacy of temozolomide in treating glioblastoma. Nanomedicine (Lond). 13(20):2579–2596. doi:10.2217/nnm-2018-0110. Epub 2018 Oct 18. PMID: 30334671.
  • Kuo YC, Tsao CW. 2017. Neuroprotection against apoptosis of SK-N-MC cells using RMP-7- and lactoferrin-grafted liposomes carrying quercetin. Int J Nanomedicine. 12:2857–2869. doi:10.2147/IJN.S132472. PMID: 28435263; PMCID: PMC5391167.
  • Lang J, Yang N, Deng J, Liu K, Yang P, Zhang G, Jiang C. 2011. Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans. PLoS One. 6:e23710. doi:10.1371/journal.pone.0023710.
  • Laterra J, Keep R, Betz LA, Goldstein GW. 1999. Blood-brain barrier. In: Siegel GJ, Agranoff BW, Albers RW, Fisher SK, Uhler MD, editors. Basic neurochemistry: molecular, cellular and medical aspects. 6th ed. Philadelphia: Lippincott-Raven.
  • Lavi E, Cong L. 2020. Type I astrocytes and microglia induce a cytokine response in an encephalitic murine coronavirus infection. Exp Mol Pathol. 115:104474. doi:10.1016/j.yexmp.2020.104474. Epub 2020 May 23. PMID: 32454103; PMCID: PMC7245307.
  • Lee NY, Cheng JT, Enomoto T, Nakamura I. 2006. The antihypertensive activity of angiotensin-converting enzyme inhibitory peptide containing in bovine lactoferrin. Chin J Physiol. 49(2):67–73.
  • Legrand D, Van Berkel PH, Salmon V, Van Veen HA, Slomianny MC, Nuijens JH, Spik G. 1997. The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells. Biochem J. 327(Pt 3):841–846. doi:10.1042/bj3270841.
  • Legrand D. 2016. Overview of Lactoferrin as a Natural Immune Modulator. J Pediatr. 173(Suppl):S10–S5. doi:10.1016/j.jpeds.2016.02.071. PMID: 27234406.
  • Legrand D, Elass E, Carpentier M, Mazurier J. 2005. Lactoferrin: a modulator of immune and inflammatory responses. Cell Mol Life Sci. 62(22):2549–2559. doi:10.1007/s00018-005-5370-2. PMID: 16261255; PMCID: PMC7079806.
  • Lehner C, Gehwolf R, Tempfer H, Krizbai I, Hennig B, Bauer HC, Bauer H. 2011. Oxidative stress and blood-brain barrier dysfunction under particular consideration of matrix metalloproteinases. Antioxid Redox Signal. 15(5):1305–1323. doi:10.1089/ars.2011.3923. Epub 2011 May 19. PMID: 21294658; PMCID: PMC6464004.
  • Leveugle B, Faucheux BA, Bouras C, Nillesse N, Spik G, Hirsch EC, Agid Y, Hof PR. 1996. Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases. Acta Neuropathol. 91(6):566–572. doi:10.1007/s004010050468. PMID: 8781654.
  • Leveugle B, Spik G, Perl DP, Bouras C, Fillit HM, Hof PR. 1994. The iron-binding protein lactotransferrin is present in pathologic lesions in a variety of neurodegenerative disorders: a comparative immunohistochemical analysis. Brain Res. 650(1):20–31. PMID: 7953673. doi:10.1016/0006-8993(94)90202-X.
  • Liao Y, Jiang R, Lönnerdal B. 2012. Biochemical and molecular impacts of lactoferrin on small intestinal growth and development during early life. Biochem Cell Biol. 90(3):476–484. doi:10.1139/o11-075. Epub 2012 Feb 14. PMID: 22332905.
  • Lim ST, Janaway B, Costello H, Trip A, Price G. 2020. Persistent psychotic symptoms following COVID-19 infection. BJPsych Open. 6(5):e105. doi:10.1192/bjo.2020.76. PMID: 32696735; PMCID: PMC7477483.
  • Liu W, Wei F, Ye A, Tian M, Han J. 2017. Kinetic stability and membrane structure of liposomes during in vitro infant intestinal digestion: Effect of cholesterol and lactoferrin. Food Chem. 230:6–13. doi:10.1016/j.foodchem.2017.03.021.
  • Liu JL, Fan YG, Yang ZS, Wang ZY, Guo C. 2018. Iron and Alzheimer's Disease: From pathogenesis to therapeutic implications. Front Neurosci. 12:632. doi:10.3389/fnins.2018.00632. PMID: 30250423; PMCID: PMC6139360.
  • Liu H, Wu H, Zhu N, Xu Z, Wang Y, Qu Y, Wang J. 2020. Lactoferrin protects against iron dysregulation, oxidative stress, and apoptosis in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson's disease in mice. J Neurochem. 152(3):397–415. doi:10.1111/jnc.14857.
  • Lönnerdal B. 1991. Lactoferrin binding to its intestinal receptor. Adv Exp Med Biol. 310:145–150. doi:10.1007/978-1-4615-3838-7_17. PMID: 1667062.
  • Lönnerdal B. 2009. Nutritional roles of lactoferrin. Curr Opin Clin Nutr Metab Care. 12(3):293–297. doi:10.1097/MCO.0b013e328328d13e. PMID: 19318940.
  • Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, et al. 2020. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 77(6):683–690. doi:10.1001/jamaneurol.2020.1127.
  • Matías-Guiu J, Gomez-Pinedo U, Montero-Escribano P, Gomez-Iglesias P, Porta-Etessam J, Matias-Guiu JA. 2020. Should we expect neurological symptoms in the SARS-CoV-2 epidemic? Neurologia. 35(3):170–175. English, Spanish. doi:10.1016/j.nrl.2020.03.001. Epub 2020 Apr 6. PMID: 32299636; PMCID: PMC7136883.
  • Matsuzaki T, Nakamura M, Nogita T, Sato A. 2019. Cellular uptake and release of intact lactoferrin and its derivatives in an intestinal enterocyte model of Caco-2 Cells. Biol Pharm Bull. 42(6):989–995. doi:10.1248/bpb.b19-00011. PMID: 31155596.
  • Mazza MG, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I, Melloni EMT, Furlan R, Ciceri F, Rovere-Querini P, et al. 2020. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav Immun. 89:594–600. doi:10.1016/j.bbi.2020.07.037. Epub 2020 Jul 30. PMID: 32738287; PMCID: PMC7390748.
  • Meng X, Deng Y, Dai Z, Meng Z. 2020. COVID-19 and anosmia: A review based on up-to-date knowledge. Am J Otolaryngol. 41(5):102581. doi:10.1016/j.amjoto.2020.102581. Epub 2020 Jun 2. PMID: 32563019; PMCID: PMC7265845.
  • Meng Q, Wang A, Hua H, Jiang Y, Wang Y, Mu H, Wu Z, Sun K. 2018. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease. Int J Nanomedicine. 13:705–718. doi:10.2147/IJN.S151474. PMID: 29440896; PMCID: PMC5798568.
  • Milewska A, Zarebski M, Nowak P, Stozek K, Potempa J, Pyrc K. 2014. Human coronavirus NL63 utilizes heparan sulfate proteoglycans for attachment to target cells. J Virol. 88(22):13221–13230. doi:10.1128/JVI.02078-14. Epub 2014 Sep 3. PMID: 25187545; PMCID: PMC4249106.
  • Miyakawa M, Kubo S, Oda H, Motoki N, Mizuki M, Tsukahara T, Tanaka M, Yamauchi K, Abe F, Nomiyama T. 2020. Effects of lactoferrin on sleep conditions in children aged 12-32 months: A preliminary, randomized, double-blind, placebo-controlled trial. Nat Sci Sleep. 12:671–677. doi:10.2147/NSS.S263106. PMID: 33061724; PMCID: PMC7532897.
  • Mochizuki H, Choong CJ, Baba K. 2020. Parkinson's disease and iron. J Neural Transm (Vienna). 127(2):181–187. doi:10.1007/s00702-020-02149-3. Epub 2020 Feb 5. PMID: 32025811.
  • Mohamed WA, Salama RM, Schaalan MF. 2019. A pilot study on the effect of lactoferrin on Alzheimer's disease pathological sequelae: Impact of the p-Akt/PTEN pathway. Biomed Pharmacother. 111:714–723. doi:10.1016/j.biopha.2018.12.118. Epub 2019 Jan 3. PMID: 30611996.
  • Montalvan V, Lee J, Bueso T, De Toledo J, Rivas K. 2020. Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review. Clin Neurol Neurosurg. 194:105921. doi:10.1016/j.clineuro.2020.105921. Epub 2020 May 15. PMID: 32422545; PMCID: PMC7227498.
  • Moore RY. 2007. Suprachiasmatic nucleus in sleep-wake regulation. Sleep Med. 8(Suppl 3):27–33. doi:10.1016/j.sleep.2007.10.003. PMID: 18032104.
  • Mosser C-A, Baptista S, Arnoux I, Audinat E. 2017. Microglia in CNS development: Shaping the brain for the future. Prog Neurobiol. 149–150:1–20. doi:10.1016/j.pneurobio.2017.01.002.
  • Naidu AS. 2000. Lactoferrin: Natural multifunctional antimicrobial. Boca Raton (FL): CRC Press. ISBN: 978–0849309090.
  • Naidu AS. 2013. Redox life (bio-rep education series). Yorba Linda (CA): Bio-Rep Media. ISBN: 978–0982445112.
  • Naidu AS, Chen J, Martinez C, Tulpinski J, Pal BK, Fowler RS. 2004. Activated lactoferrin's ability to inhibit Candida growth and block yeast adhesion to the vaginal epithelial monolayer. J Reprod Med. 49(11):859–866. PMID: 15603095.
  • Naidu SAG, Clemens RA, Pressman P, Zaigham M, Davies KJA, Naidu AS. 2020b. COVID-19 during Pregnancy and Postpartum: II) Antiviral spectrum of maternal lactoferrin in fetal and neonatal defense. J Diet Suppl. 8:1–37. doi:10.1080/19390211.2020.1834047. Epub ahead of print. PMID: 33164606.
  • Naidu SAG, Clemens RA, Pressman P, Zaigham M, Kadkhoda K, Davies KJA, Naidu AS. 2020a. COVID-19 during Pregnancy and Postpartum: I) Pathobiology of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) at maternal-fetal interface. J Diet. Suppl.8:1–28. doi:10.1080/19390211.2020.1834049. Epub ahead of print. PMID: 33164601.
  • National Institute of Mental Health (NIMH). 2019. Prevalence of any mental illness in 2019 – Statistics. https://www.nimh.nih.gov/health/statistics/mental-illness.shtml.
  • Naughton SX, Raval U, Pasinetti GM. 2020. Potential Novel Role of COVID-19 in Alzheimer's Disease and preventative mitigation strategies. J Alzheimers Dis. 76(1):21–25. doi:10.3233/JAD-200537. PMID: 32538855.
  • Niazkar HR, Zibaee B, Nasimi A, Bahri N. 2020. The neurological manifestations of COVID-19: a review article. Neurol Sci. 41(7):1667–1671. doi:10.1007/s10072-020-04486-3. Epub 2020 Jun 1. PMID: 32483687; PMCID: PMC7262683.
  • Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, Marras C, Tanner CM, Ross GW, Langston JW, Klein C, Bonifati V, Jankovic J, Lozano AM, Deuschl G, Bergman H, Tolosa E, Rodriguez-Violante M, Fahn S, Postuma RB, Berg D, Marek K, Standaert DG, Surmeier DJ, Olanow CW, Kordower JH, Calabresi P, Schapira AHV, Stoessl AJ. 2017. Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy. Mov Disord. 32(9):1264–1310. doi:10.1002/mds.27115. PMID: 28887905; PMCID: PMC5685546.
  • Olsen I, Singhrao SK. 2021. Low levels of salivary lactoferrin may affect oral dysbiosis and contribute to Alzheimer's disease: A hypothesis. Med Hypotheses. 146:110393. Epub ahead of print. PMID: 33229194. doi:10.1016/j.mehy.2020.110393.
  • Osmand AP, Switzer RC. III. 1991. Differential distribution of lactoferrin and Alz-50 immunoreactivities in neuritic plaques and neurofibrillary tangles. In: Iqbal K, McLachlan DRC, Winblad B, Wisniewski HM, editors. Alzheimer's disease: Basic mechanisms, diagnosis and therapeutic strategies. New York: John Wiley and Sons. p. 219–228.
  • Padhan K, Minakshi R, Towheed MAB, Jameel S. 2008. Severe acute respiratory syndrome coronavirus 3a protein activates the mitochondrial death pathway through p38 MAP kinase activation. J Gen Virol. 89(Pt 8):1960–1969. doi:10.1099/vir.0.83665-0. PMID: 18632968.
  • Pandey A, Singh K, Patel S, Singh R, Patel K, Sawant K. 2019. Hyaluronic acid tethered pH-responsive alloy-drug nanoconjugates for multimodal therapy of glioblastoma: An intranasal route approach. Mater Sci Eng C Mater Biol Appl. 98:419–436. doi:10.1016/j.msec.2018.12.139. Epub 2019 Jan 3. PMID: 30813043.
  • Pardridge WM. 2007. Drug targeting to the brain. Pharm Res. 24(9):1733–1744. doi:10.1007/s11095-007-9324-2. Epub 2007 Jun 7. PMID: 17554607.
  • Patrick LR. 2007. Restless legs syndrome: pathophysiology and the role of iron and folate. Altern Med Rev. 12(2):101–112. PMID: 17604457.
  • Pietrantoni A, Fortuna C, Remoli ME, Ciufolini MG, Superti F. 2015. Bovine lactoferrin inhibits Toscana virus infection by binding to heparan sulphate. Viruses. 7(2):480–495. doi:10.3390/v7020480. PMID: 25643293; PMCID: PMC4353899.
  • Rodriguez-Perez AI, Garrido-Gil P, Pedrosa MA, Garcia-Garrote M, Valenzuela R, Navarro G, Franco R, Labandeira-Garcia JL. 2020. Angiotensin type 2 receptors: Role in aging and neuroinflammation in the substantia nigra. Brain Behav Immun. 87:256–271. doi:10.1016/j.bbi.2019.12.011. Epub 2019 Dec 19. PMID: 31863823.
  • Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, Zandi MS, Lewis G, David AS. 2020. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 7(7):611–627. doi:10.1016/S2215-0366(20)30203-0. Epub 2020 May 18. PMID: 32437679; PMCID: PMC7234781.
  • Rousseau E, Michel PP, Hirsch EC. 2013. The iron-binding protein lactoferrin protects vulnerable dopamine neurons from degeneration by preserving mitochondrial calcium homeostasis. Mol Pharmacol. 84(6):888–898. doi:10.1124/mol.113.087965.
  • Sacharczuk M, Zagulski T, Sadowski B, Barcikowska M, Pluta R. 2005. Laktoferyna w ośrodkowym układzie nerwowym [Lactoferrin in the central nervous system]. Neurol Neurochir Pol. 39(6):482–489.
  • Semenza GL. 2000. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol (1985). 88(4):1474–1480. doi:10.1152/jappl.2000.88.4.1474. PMID: 10749844.
  • Serrano G, Kochergina I, Albors A, Diaz E, Oroval M, Hueso G, Serrano JM. 2020. Liposomal lactoferrin as potential prevention and cure for COVID-19. IJRHS. 8(1):8–15. doi:10.5530/ijrhs.8.1.3.
  • Seyfried TN. 2015. Cancer as a mitochondrial metabolic disease. Front Cell Dev Biol. 3:43. doi:10.3389/fcell.2015.00043. PMID: 26217661; PMCID: PMC4493566.
  • Sharif Y, Jumah F, Coplan L, Krosser A, Sharif K, Tubbs RS. 2018. Blood brain barrier: A review of its anatomy and physiology in health and disease. Clin Anat. 31(6):812–823. doi:10.1002/ca.23083.
  • Sher L. 2020. The impact of the COVID-19 pandemic on suicide rates. QJM. 113(10):707–712. doi:10.1093/qjmed/hcaa202. PMID: 32539153; PMCID: PMC7313777.
  • Shimmura S, Shimoyama M, Hojo M, Urayama K, Tsubota K. 1998. Reoxygenation injury in a cultured corneal epithelial cell line protected by the uptake of lactoferrin. Invest Ophthalmol Vis Sci. 39(8):1346–1351. Pmid: 9660482.
  • Siebert PD, Huang BC. 1997. Identification of an alternative form of human lactoferrin mRNA that is expressed differentially in normal tissues and tumor-derived cell lines. Proc Natl Acad Sci U S A. 94(6):2198–2203. doi:10.1073/pnas.94.6.2198. PMID: 9122171; PMCID: PMC20064.
  • Sies H. 2017. Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: Oxidative eustress. Redox Biol. 11:613–619. doi:10.1016/j.redox.2016.12.035. Epub 2017 Jan 5. PMID: 28110218; PMCID: PMC5256672.
  • Sindhwani S, Syed AM, Ngai J, Kingston BR, Maiorino L, Rothschild J, MacMillan P, Zhang Y, Rajesh NU, Hoang T, et al. 2020. The entry of nanoparticles into solid tumours. Nat Mater. 19(5):566–575. doi:10.1038/s41563-019-0566-2. Epub 2020 Jan 13. PMID: 31932672.
  • Singh I, Swami R, Pooja D, Jeengar MK, Khan W, Sistla R. 2016. Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting. J Drug Target. 24(3):212–223. doi:10.3109/1061186X.2015.1068320.
  • Siqueiros-Cendón T, Arévalo-Gallegos S, Iglesias-Figueroa BF, García-Montoya IA, Salazar-Martínez J, Rascón-Cruz Q. 2014. Immunomodulatory effects of lactoferrin. Acta Pharmacol Sin. 35(5):557–566. doi:10.1038/aps.2013.200. PMID: 24786230; PMCID: PMC4814036.
  • Sriramoju B, Kanwar RK, Kanwar JR. 2015. Lactoferrin induced neuronal differentiation: A boon for brain tumours. Int J Dev Neurosci. 41:28–36. doi:10.1016/j.ijdevneu.2014.12.005. Epub 2014 Dec 8. PMID: 25498991.
  • Steardo L, Steardo L, Jr, Zorec R, Verkhratsky A. 2020. Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19. Acta Physiol (Oxf). 229(3):e13473. doi:10.1111/apha.13473. Epub 2020 Apr 11. PMID: 32223077; PMCID: PMC7228251.
  • Suzuki YA, Lopez V, Lönnerdal B. 2005. Mammalian lactoferrin receptors: structure and function. Cell Mol Life Sci. 62(22):2560–2575. doi:10.1007/s00018-005-5371-1. PMID: 16261254.
  • Suzuki YA, Wong H, Ashida KY, Schryvers AB, Lönnerdal B. 2008. The N1 domain of human lactoferrin is required for internalization by caco-2 cells and targeting to the nucleus. Biochemistry. 47(41):10915–10920. doi:10.1021/bi8012164. Epub 2008 Sep 12. PMID: 18785755; PMCID: PMC2668574.
  • Takeuchi T, Matsunaga K, Sugiyama A. 2017. Antidepressant-like effect of milk-derived lactoferrin in the repeated forced-swim stress mouse model. J Vet Med Sci. 79(11):1803–1806. doi:10.1292/jvms.17-0200.
  • Takeuchi T, Hayashida K-i, Inagaki H, Kuwahara M, Tsubone H, Harada E. 2003. Opioid mediated suppressive effect of milk-derived lactoferrin on distress induced by maternal separation in rat pups. Brain Res. 979(1–2):216–224. doi:10.1016/S0006-8993(03)02941-X.
  • Tay MZ, Poh CM, Rénia L. 2020. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 20:363–374. doi:10.1038/s41577-020-0311-8.
  • Terent A, Hällgren R, Venge P, Bergström K. 1981. Lactoferrin, lysozyme, and beta 2-microglobulin in cerebrospinal fluid. Elevated levels in patients with acute cerebrovascular lesions as indices of inflammation. Stroke. 12(1):40–46. doi:10.1161/01.str.12.1.40. PMID: 6164135.
  • Thomas C, Mackey MM, Diaz AA, Cox DP. 2009. Hydroxyl radical is produced via the Fenton reaction in submitochondrial particles under oxidative stress: implications for diseases associated with iron accumulation. Redox Rep. 14(3):102–108. doi:10.1179/135100009X392566. PMID: 19490751.
  • Thompson RS, Roller R, Mika A, Greenwood BN, Knight R, Chichlowski M, Berg BM, Fleshner M. 2017. Dietary prebiotics and bioactive milk fractions improve NREM sleep, enhance REM sleep rebound and attenuate the stress-induced decrease in diurnal temperature and gut microbial alpha diversity. Front Behav Neurosci. 10:240. doi:10.3389/fnbeh201600240. PMID: 28119579; PMCID: PMC5223485.
  • Tremblay ME, Madore C, Bordeleau M, Tian L, Verkhratsky A. 2020. Neuropathobiology of COVID-19: The Role for Glia. Front Cell Neurosci. 14:592214. doi:10.3389/fncel.2020.592214. PMID: 33304243; PMCID: PMC7693550.
  • Tsuchiya T, Takeuchi T, Hayashida K, Shimizu H, Ando K, Harada E. 2006. Milk-derived lactoferrin may block tolerance to morphine analgesia. Brain Res. 1068(1):102–108. doi:10.1016/j.brainres.2005.11.002.
  • Tuccari G, Giuffrè G, Crisafulli C, Barresi G. 1999. Immunohistochemical detection of lactoferrin in human astrocytomas and multiforme glioblastomas. Eur J Histochem. 43(4):317–322. PMID: 10682270.
  • Tysnes OB, Storstein A. 2017. Epidemiology of Parkinson's disease. J Neural Transm (Vienna). 124(8):901–905. doi:10.1007/s00702-017-1686-y. Epub 2017 Feb 1. PMID: 28150045.
  • U.S. Department of Health & Human Services (DH&HS). 2020. https://www.mentalhealth.gov/basics/what-is-mental-health. Accessed on 12/28/.
  • Vaira LA, Salzano G, Deiana G, De Riu G. 2020. Anosmia and Ageusia: Common findings in COVID-19 patients. Laryngoscope. 130(7):1787. doi:10.1002/lary.28692. Epub 2020 Apr 15. PMID: 32237238; PMCID: PMC7228304.
  • van de Looij Y, Ginet V, Chatagner A, Toulotte A, Somm E, Hüppi PS, Sizonenko SV. 2014. Lactoferrin during lactation protects the immature hypoxic-ischemic rat brain. Ann Clin Transl Neurol. 1(12):955–967. doi:10.1002/acn3.138. Epub 2014 Dec 2. PMID: 25574471; PMCID: PMC4284122.
  • Varatharaj A, Thomas N, Ellul MA, Davies NWS, Pollak TA, et al. 2020. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. 7(10):875–882. doi:10.1016/S2215-0366(20)30287-X.
  • Vargas G, Medeiros Geraldo LH, Gedeão Salomão N, Viana Paes M, Regina Souza Lima F, Carvalho Alcantara Gomes F. 2020. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and glial cells: Insights and perspectives. Brain Behav Immun Health. 7:100127. doi:10.1016/j.bbih.2020.100127. Epub 2020 Aug 13. PMID: 32838339; PMCID: PMC7423575.
  • Vigo D, Thornicroft G, Atun R. 2016. Estimating the true global burden of mental illness. Lancet Psychiatry. 3(2):171–178. PMID: 26851330. doi:10.1016/S2215-0366(15)00505-2.
  • Volden J, Jørgensen CE, Rukke EO, Egelandsdal B. 2012. Oxidative properties of lactoferrins of different iron-saturation in an emulsion consisting of metmyoglobin and cod liver oil. Food Chem. 132(3):1236–1243. Epub 2011 Nov 25. PMID: 29243606. doi:10.1016/j.foodchem.2011.11.092.
  • Wakabayashi H, Oda H, Yamauchi K, Abe F. 2014. Lactoferrin for prevention of common viral infections. J Infect Chemother. 20(11):666–671. doi:10.1016/j.jiac.2014.08.003. Epub 2014 Aug 30. PMID: 25182867.
  • Wallace TC, Bultman S, D'Adamo C, Daniel CR, Debelius J, Ho E, Eliassen H, Lemanne D, Mukherjee P, Seyfried TN, et al. 2019. Personalized nutrition in disrupting cancer - Proceedings from the 2017 American College of Nutrition Annual Meeting. J Am Coll Nutr. 38(1):1–14. doi:10.1080/07315724.2018.1500499. Epub 2018 Dec 4. Erratum in: J Am Coll Nutr. 2019 Sep-Oct;38(7):659. PMID: 30511901.
  • Wang B. 2016. Molecular determinants of milk lactoferrin as a bioactive compound in early neurodevelopment and cognition. J Pediatr. 173(Suppl):S29–S36. doi:10.1016/j.jpeds.2016.02.073.
  • Wang J, Bi M, Liu H, Song N, Xie J. 2015. The protective effect of lactoferrin on ventral mesencephalon neurons against MPP + is not connected with its iron binding ability. Sci Rep. 5(1):10729. PMID: 26035688; PMCID: PMC4451802. doi:10.1038/srep10729.
  • Wang GL, Jiang BH, Rue EA, Semenza GL. 1995. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A. 92(12):5510–5514. doi:10.1073/pnas.92.12.5510. PMID: 7539918; PMCID: PMC41725.
  • Wang L, Sato H, Zhao S, Tooyama I. 2010. Deposition of lactoferrin in fibrillar-type senile plaques in the brains of transgenic mouse models of Alzheimer's disease. Neurosci Lett. 481(3):164–167. Epub 2010 Jul 3. PMID: 20599473. doi:10.1016/j.neulet.2010.06.079.
  • Wang T, Xu SF, Fan YG, Li LB, Guo C. 2019. Iron pathophysiology in Alzheimer's Diseases. Adv Exp Med Biol. 1173:67–104. doi:10.1007/978-981-13-9589-5_5. PMID: 31456206.
  • Xu SF, Zhang YH, Wang S, Pang ZQ, Fan YG, Li JY, Wang ZY, Guo C. 2019. Lactoferrin ameliorates dopaminergic neurodegeneration and motor deficits in MPTP-treated mice. Redox Biol. 21:101090. doi:10.1016/j.redox.2018.101090. Epub 2018 Dec 21. PMID: 30593976; PMCID: PMC6307097.
  • Yachou Y, El Idrissi A, Belapasov V, Ait Benali S. 2020. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients. Neurol Sci. 41(10):2657–2669. doi:10.1007/s10072-020-04575-3. Epub 2020 Jul 28. PMID: 32725449; PMCID: PMC7385206.
  • Yu SY, Sun L, Liu Z, Huang XY, Zuo LJ, Cao CJ, Zhang W, Wang XM. 2013. Sleep disorders in Parkinson's disease: clinical features, iron metabolism and related mechanism. PLoS One. 8(12):e82924. Published 2013 Dec 23. doi:10.1371/journal.pone.0082924.
  • Zakharova ET, Sokolov AV, Pavlichenko NN, Kostevich VA, Abdurasulova IN, et al. 2018. Erythropoietin and Nrf2: key factors in the neuroprotection provided by apo-lactoferrin. Biometals. 31(3):425–443. doi:10.1007/s10534-018-0111-9. Epub 2018 May 10. PMID: 29748743.
  • Zhang Y, Lima CF, Rodrigues LR. 2014. Anticancer effects of lactoferrin: underlying mechanisms and future trends in cancer therapy. Nutr Rev. 72(12):763–773. doi:10.1111/nure.12155. Epub 2014 Nov 18. PMID: 25406879.
  • Zhang Z, Yang J, Min Q, Ling C, Maiti D, Xu J, Qin L, Yang K. 2019. Holo-lactoferrin modified liposome for relieving tumor hypoxia and enhancing radiochemotherapy of cancer. Small. 15(6):e1803703. doi:10.1002/smll.201803703. Epub 2019 Jan 15. PMID: 30645056.
  • Zheng J, Xie Y, Li F, Zhou Y, Qi L, Liu L, Chen Z. 2020. Lactoferrin improves cognitive function and attenuates brain senescence in aged mice. J Funct Foods. 65:103736. doi:10.1016/j.jff.2019.103736.
  • Zimecki M, Artym J. 2004. Wpływ stresu psychicznego na odpowiedź immunologiczna [The effect of psychic stress on the immune response]. Postepy Hig Med Dosw (Online). 58:166–175. Published 2004 Mar 24.
  • Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. 2020. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: A review. JAMA Neurol. 77(8):1018–1027. doi:10.1001/jamaneurol.2020.2065.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.